André C Knulst Selected Research

hypoxanthine arabinoside (ara-H)

1/2021	Diagnostic accuracy of Ara h 2 for detecting peanut allergy in children.
1/2021	Accurate Prediction of Peanut Allergy in One-Third of Adults Using a Validated Ara h 2 Cutoff.
1/2017	The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children.
11/2013	Ara h 2 is the best predictor for peanut allergy in adults.
1/2013	The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model.
12/2004	Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
2/2003	Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André C Knulst Research Topics

Disease

28	Hypersensitivity (Allergy) 10/2021 - 12/2002
11	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 02/2003
10	Food Hypersensitivity (Food Allergy) 10/2021 - 12/2004
8	Anaphylaxis (Anaphylactic Shock) 01/2022 - 02/2003
5	Angioedema 12/2022 - 01/2015
5	Chronic Urticaria 07/2021 - 01/2017
4	Seasonal Allergic Rhinitis (Hay Fever) 01/2021 - 09/2002
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2013
2	Milk Hypersensitivity (Milk Allergy) 02/2008 - 12/2002
1	Psoriatic Arthritis 11/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022
1	Urticaria (Hives) 07/2021
1	Nut Hypersensitivity (Nut Allergy) 12/2020
1	Egg Hypersensitivity (Egg Allergy) 12/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Parasitic Diseases (Parasitic Disease) 01/2016
1	Noncommunicable Diseases 01/2016
1	Inflammation (Inflammations) 01/2016
1	Confusion (Bewilderment) 04/2015
1	Hereditary Angioedemas 01/2015
1	Hepatitis A (Hepatitis, Infectious) 05/2014
1	Infections 01/2014
1	Drug-Related Side Effects and Adverse Reactions 06/2013
1	Allergic Rhinitis 01/2013

Drug/Important Bio-Agent (IBA)

24	Immunoglobulin E (IgE)IBA 01/2021 - 09/2002
15	AllergensIBA 01/2022 - 10/2003
7	hypoxanthine arabinoside (ara-H)IBA 01/2021 - 02/2003
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2002
5	AntibodiesIBA 05/2014 - 12/2004
3	Omalizumab (Xolair)FDA Link 07/2021 - 01/2020
3	Histamine Antagonists (Antihistamines)IBA 01/2020 - 01/2017
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 12/2022 - 01/2016
2	BradykininIBA 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2011
2	Immunoglobulin G (IgG)IBA 01/2016 - 10/2013
2	lipid transfer protein (glycolipid transfer protein)IBA 08/2015 - 02/2008
1	GlucocorticoidsIBA 11/2022
1	Complement System Proteins (Complement)IBA 07/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2021
1	CarbohydratesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020
1	EpitopesIBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	hydroxide ionIBA 01/2019
1	Milk Proteins (Milk Protein)IBA 01/2018
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2017
1	daratumumabIBA 01/2017
1	C-Reactive ProteinIBA 01/2016
1	TabletsIBA 12/2014
1	Inulin FDA Link 12/2014
1	Silicon Dioxide (Silica)FDA LinkGeneric 12/2014
1	stearic acid (magnesium stearate)FDA LinkGeneric 12/2014
1	VaccinesIBA 01/2014
1	Complement Receptors (Complement Receptor)IBA 10/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2013
1	ParvalbuminsIBA 11/2008
1	Profilins (Profilin)IBA 06/2008
1	Pepsin A (Pepsin)IBA 12/2004
1	Peanut OilIBA 05/2004
1	Indicators and Reagents (Reagents)IBA 10/2003
1	plant vicilin proteinIBA 02/2003

Therapy/Procedure

3	Immunotherapy 10/2018 - 01/2011
2	Therapeutics 01/2019 - 05/2004